STIM.NASDAQNeuronetics, INC

Form 4: Neuronetics CFO Stephen Furlong Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold 14,836 shares of common stock on February 10, 2025, to cover tax withholding obligations.

Summary

  • On February 10, 2025, Stephen Furlong, the EVP, CFO, and Treasurer of Neuronetics, Inc., sold 14,836 shares of the company's common stock.
  • The sale was executed to satisfy the reporting person's tax withholding obligation upon the vesting of a portion of a restricted stock unit award.
  • The shares were sold at a weighted average price of $3.28.
  • Following the transaction, Furlong directly owns 482,572 shares of Neuronetics common stock.
  • A power of attorney was granted to Patrick Devine, Nusrat Samjani, W. Andrew Macan, Francis Brown, Brian Short, and Kelly Duffner to handle SEC filings related to Neuronetics securities.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction reflects a standard financial planning activity and doesn't necessarily indicate a change in the executive's confidence in the company.

Comparison to Industry Standards

  • Executive stock sales for tax purposes are a common occurrence across publicly traded companies.
  • Comparing Furlong's transaction to similar sales by executives at comparable medical device companies like Medtronic or Boston Scientific would provide context on the scale and impact of this sale.
  • For example, if executives at similar companies routinely sell a larger percentage of their holdings for tax purposes, this transaction might be viewed as less significant.

Stakeholder Impact

  • The sale of shares by a company executive could have a minor impact on shareholder perception, but is unlikely to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
04/01/2024Date of execution for Power of Attorney granted by Stephen Furlong.
02/10/2025Date of stock sale transaction by Stephen Furlong.
02/12/2025Date of signature for the Form 4 filing.

Keywords

Neuronetics, Stephen Furlong, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership, STIM

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.